Search Results - "Gogarnoiu, Emma S."
-
1
Anaerobic Hydroxylation of C(sp3)–H Bonds Enabled by the Synergistic Nature of Photoexcited Nitroarenes
Published in Journal of the American Chemical Society (08-02-2023)“…A photoexcited-nitroarene-mediated anaerobic C–H hydroxylation of aliphatic systems is reported. The success of this reaction is due to the bifunctional nature…”
Get full text
Journal Article -
2
Photoinduced Oxygen Transfer Using Nitroarenes for the Anaerobic Cleavage of Alkenes
Published in Journal of the American Chemical Society (31-08-2022)“…Herein we report the anaerobic cleavage of alkenes into carbonyl compounds using nitroarenes as oxygen transfer reagents under visible light. This approach…”
Get full text
Journal Article -
3
Dopamine D 3 /D 2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Published in Journal of medicinal chemistry (09-02-2023)“…Highly selective dopamine D receptor (D R) partial agonists/antagonists have been developed for the treatment of psychostimulant use disorders (PSUD). However,…”
Get full text
Journal Article -
4
A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder
Published in Neuropsychopharmacology (New York, N.Y.) (01-12-2022)“…The non-medical use of opioids has become a national crisis in the USA. Developing non-opioid pharmacotherapies for controlling this opioid epidemic is urgent…”
Get full text
Journal Article -
5
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Published in Journal of medicinal chemistry (09-02-2023)“…Highly selective dopamine D3 receptor (D3R) partial agonists/antagonists have been developed for the treatment of psychostimulant use disorders (PSUD)…”
Get full text
Journal Article -
6
A highly D 3 R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D 3 R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder
Published in Neuropsychopharmacology (New York, N.Y.) (01-12-2022)“…The non-medical use of opioids has become a national crisis in the USA. Developing non-opioid pharmacotherapies for controlling this opioid epidemic is urgent…”
Get full text
Journal Article